Enliven Therapeutics Inc (ELVN) - News Archive

Enliven Therapeutics has garnered attention in the biopharmaceutical landscape with the recent announcement of positive updates from its Phase 1 clinical trial for ELVN-001, a promising therapeutic candidate aimed at tr...

Enliven Therapeutics, a leading drug discovery and development company, has recently announced heartening results from the novel Phase 1 clinical trial of their revolutionary drug ELVN-001, targeted at combating Chronic...

Enliven Therapeutics Presents Exciting Data on Revolutionary Cancer Drug ELVN-001 in Virtual Key Opinion Leader EventBOULDER, Colo., March 28, 2024 - Enliven Therapeutics, Inc. (Nasdaq: ELVN), a leading clinical-stage p...

In recent news, Enliven Therapeutics has made significant strides towards advancing their innovative therapeutic treatments with the announcement of a successful $90 million private placement financing. This substantial...